Briefing
ctDNA monitoring in hepatocellular carcinoma and metastatic colorectal cancer
Interventional study of serial ctDNA in hepatocellular carcinoma and in colorectal cancer metastatic to the liver. The registry lists the phase as not applicable and the primary outcome as assessment of the clinical value of the ctDNA level. ClinicalTrials.gov lists the study as recruiting.
- Design: Not applicable · Recruiting